Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_221
Snippet: Disclosures: No disclosures to report. Recently, a validated pharmacodynamic assay (PD) has been used to monitor dogs treated with cyclosporine by assessing interleukin-2 (IL-2) and interferon-gamma (INFc). There is no study to date looking at cytokine secretion and detection in dogs receiving other immunosuppressive drugs. The aim of this study was to evaluate multiple immunosuppressive drugs and determine individually whether they affected secr.....
Document: Disclosures: No disclosures to report. Recently, a validated pharmacodynamic assay (PD) has been used to monitor dogs treated with cyclosporine by assessing interleukin-2 (IL-2) and interferon-gamma (INFc). There is no study to date looking at cytokine secretion and detection in dogs receiving other immunosuppressive drugs. The aim of this study was to evaluate multiple immunosuppressive drugs and determine individually whether they affected secretion of IL-2, IL-6, IL-10, INFc or tumor necrosis factor alpha (TNFa) in healthy dogs using a multiplex assay.
Search related documents:
Co phrase search for related documents- cytokine secretion and necrosis factor: 1, 2, 3, 4, 5, 6, 7, 8, 9
- cytokine secretion and necrosis factor alpha: 1, 2, 3
- cytokine secretion and pharmacodynamic assay: 1
- date study and healthy dog: 1
- date study and necrosis factor: 1, 2
- date study and necrosis factor alpha: 1
- immunosuppressive drug and multiple immunosuppressive drug: 1
- multiplex assay and necrosis factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- multiplex assay and necrosis factor alpha: 1, 2
Co phrase search for related documents, hyperlinks ordered by date